Nucleonics
About:
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Top Investors: New Enterprise Associates, SR One, HealthCap, Burrill & Company, Quaker BioVentures
Description:
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Total Funding Amount:
$51.4M
Headquarters Location:
Langhorne, Pennsylvania, United States
Founded Date:
2001-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2004-06-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai